CRYSTAL SHAW: Open Payments
NPI 1205430964 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 12 payments from 5 companies in 2025. Trend: 2023 $37 · 2024 $208 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $44 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: JARDIANCE, LifeVest, VERQUVO, NUZYRA, LEQVIO.
Industry payments across MS — which companies pay providers there.
